Richard Soucier is a Cardiology physician affiliated with Trinity Health. OpenAlex indexes 37 publications with 369 citations (h-index 9); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
114 Woodland St
Hartford, CT 061051208
Telephone
860-714-4820Provider last certified this registry record 11 Nov 2021.
Clinical trials
- Effect of Post Discharge Follow-up on Readmission Rates for Congestive Heart Failure Patients
Sponsor: Trinity Health Of New England
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
20 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20258 payments
- E.R. Squibb & Sons, L.L.C.Program year20256 payments
- Novartis Pharmaceuticals CorporationProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
73.7%Loop diuretic21.2%Furosemide84%Torsemide9%Bumetanide7%Part D<11 patientsAldosterone antagonist (MRA)16.8%Spironolactone100%Part D≥67 patients+ 8 more classes in this area
Blood & clotting
13.9%Factor Xa inhibitor13.9%Eliquis59%Xarelto42%Part D≥19 patientsMetabolism & gastrointestinal
12.4%SGLT2 inhibitor12.4%Farxiga53%Jardiance47%Part D≥23 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The Presence Of Clinical COPD Predicts Mortality In Heart Failure Patient Population
Journal of Cardiac Failure
2023 - Natriuretic Equation to Predict Loop Diuretic Response in Patients With Heart Failure
Journal of the American College of Cardiology
2021 - Psychological stress in heart failure: a potentially actionable disease modifier
Heart Failure Reviews
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Zuwallack, MD
Trinity Health
James Figge, MD
Trinity Health
Bruno Digiovine, MD
Trinity Health
Mohammad Jazayeri, MD
Trinity Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”